HCPCS Level II code S9988 denotes services provided as part of a Phase I clinical trial. The code captures clinical trial–related patient care and research activities during early-stage human studies, which are critical for assessing safety, dosing, and feasibility of new therapies. Nationally, accurate reporting of such services supports research billing transparency, appropriate reimbursement pathways, and consistent documentation for trial sponsors and payers.

Key payers in the national landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise outline of the code’s clinical application, typical sites of service, common billing modifiers, and where this code fits in research billing workflows. The publication also provides context on payer coverage considerations and coding practice implications relevant to hospitals, academic research centers, and outpatient research clinics.

This summary equips billing and compliance teams, clinical trial administrators, and policy analysts with a clear reference for S9988 — what it represents, why it matters in the clinical research and reimbursement ecosystem, and the main topics covered in the full publication (benchmarks, policy updates, and clinical context).